Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HNF4A | P41235 | 1/20 | 0.50 |
| ▸ | FABP3 | P05413 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.46 |
| ▸ | IKBKB | O14920 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135374 | 0.85 | PLK1 (0.45) | HNF4ANPC1RAB9AALDH1A1MAPT | |
| SCHEMBL18230845 | 0.85 | POLB (0.51) | NPC1RAB9AALDH1A1MAPTPOLB | |
| SCHEMBL9958891 | 0.80 | POLB (0.60) | NPC1RAB9AALDH1A1MAPTPOLB | |
| SCHEMBL1467307 | 0.80 | HNF4A (0.54) | HNF4AFABP3FABP4FABP5IKBKB | |
| SCHEMBL3362915 | 0.79 | HNF4A (0.58) | HNF4AFABP3FABP4FABP5ALDH1A1 | |
| SCHEMBL8773868 | 0.78 | ALB (0.47) | ADORA3ADORA2ANPC1RAB9AADORA2B | |
| SCHEMBL338541 | 0.77 | MAPT (0.43) | IKBKBADORA3ADORA2ANPC1RAB9A | |
| SCHEMBL135375 | 0.77 | ADORA3 (0.44) | HNF4AIKBKBADORA3ADORA2ANPC1 | |
| SCHEMBL6206191 | 0.76 | ALDH1A1 (0.69) | NPC1RAB9AALDH1A1MAPTGAA | |
| SCHEMBL31307595 | 0.75 | HNF4A (0.46) | HNF4AFABP3FABP4FABP5NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290291-A | Synthesis method of dihydro oat alkaloid D | 微著生物科技(东营)有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024110023-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024078679-A1 | A FRAGRANCE MIXTURE (VI) | SYMRISE AG (DE) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024061476-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024051922-A1 | A FRAGRANCE MIXTURE (III) | SYMRISE AG (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4330265-A1 | MICROBIAL GLYCOLIPIDS | Analyticon Discovery GmbH (DE) | 2024-03-06 | — | — | EP | disclosed |
| EP-4326251-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND, OPTIONALLY, BISABOLOL | Symrise AG (DE) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024037712-A1 | 1-CYCLOOCTYLPROPAN-2-ONE AS A FRAGRANCE | SYMRISE AG (DE) | 2024-02-22 | — | — | WO | disclosed |
| EP-4322911-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | Symrise AG (DE) | 2024-02-21 | — | — | EP | disclosed |
| WO-2024027922-A1 | A FRAGRANCE MIXTURE (II) | SYMRISE AG (DE) | 2024-02-08 | — | — | WO | disclosed |
| WO-2022111829-A1 | ESSENTIAL OILS OF CITRUS FRUITS FOR USE AS MEDICAMENT FOR INDUCED, INCREASED AND/OR ACCELERATED AUTOPHAGY IN HUMAN KERATINOCYTES | SYMRISE AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| EP-3982910-A1 | A COOLING PREPARATION | Symrise AG (DE) | 2022-04-20 | — | — | EP | disclosed |
| EP-3938055-A1 | AN ANTIMICROBIAL MIXTURE | Symrise AG (DE) | 2022-01-19 | — | — | EP | disclosed |
| WO-2021228840-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2021-11-18 | — | — | WO | disclosed |
| WO-2020249216-A1 | A COOLING PREPARATION | SYMRISE AG (DE) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020182318-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2020-09-17 | — | — | WO | disclosed |
| US-9445988-B2 | Extracts of Tetraselmis sp | SYMRISE AG (DE) | 2016-09-20 | — | — | US | disclosed |
| US-9125936-B2 | Ginger extract for the protection of stem cells | SYMRISE AG (DE) | 2015-09-08 | — | — | US | disclosed |
| US-20140242020-A1 | Ginger Extract for the Protection of Stem Cells | SYMRISE AG (DE) | 2014-08-28 | — | — | US | disclosed |
| US-20100143267-A1 | EXTRACTS OF TETRASELMIS SP. | SYMRISE GMBH & CO. KG (DE) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140242020-A1 | Ginger Extract for the Protection of Stem Cells | HSD11B1, HSD3B1, EBP | HNF4A 19/4885FABP3 861/4885FABP4 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.